Xu Xiaoying, Zhou Qiao, Korfmacher Walter A
Department of Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
Rapid Commun Mass Spectrom. 2005;19(15):2131-6. doi: 10.1002/rcm.2040.
The demand for high sensitivity bioanalytical methods has dramatically increased in the drug discovery stage; in addition, there has been a growing trend of reducing the sample volume that is required for these assays. A sensitive high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS) procedure has been developed and tested to meet these needs. The assay requires only a low plasma sample volume (10 microL) and employs a protein precipitation procedure using a 1:6 plasma/acetonitrile ratio. The supernatant is injected directly into the LC/MS/MS system using the selected reaction monitoring (SRM) procedure for detection. A generic HPLC gradient based on a methanol/water mobile phase with a flow rate set to 0.8 mL/min was used. The test method showed very good linearity between 0.1-1000 ng/mL (R2 = 0.9737), precision (%RSD = 6-9), accuracy (%RE = -2) and reproducibility (%RSD = 11). A drug discovery IV/PO study was assayed using both the new low volume method and our standard volume (50 microL) method. The correlation of the two sets of data from the two methods was excellent (R2 = 0.9287). This new assay procedure has been successfully used in our laboratory for over 100 different rat or mouse discovery PK studies.
在药物发现阶段,对高灵敏度生物分析方法的需求急剧增加;此外,减少这些分析所需样品体积的趋势也在不断增强。为满足这些需求,已开发并测试了一种灵敏的高效液相色谱/串联质谱(HPLC/MS/MS)方法。该分析仅需少量血浆样品(10微升),并采用血浆与乙腈比例为1:6的蛋白沉淀方法。使用选择反应监测(SRM)程序将上清液直接注入LC/MS/MS系统进行检测。采用基于甲醇/水流动相、流速设定为0.8毫升/分钟的通用HPLC梯度。该测试方法在0.1 - 1000纳克/毫升之间显示出非常好的线性(R2 = 0.9737)、精密度(%RSD = 6 - 9)、准确度(%RE = -2)和重现性(%RSD = 11)。使用新的低体积方法和我们的标准体积(50微升)方法对一项药物发现静脉注射/口服研究进行了分析。两种方法的两组数据相关性极佳(R2 = 0.9287)。这种新的分析方法已在我们实验室成功用于100多项不同的大鼠或小鼠发现阶段的药代动力学研究。